Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Peraso
PRSO
$10.4M
| $124K | ﹤0.01% |
6,263
+5,575
| +810% | +$112K |
|
3427
Focus Universal
FCUV
$3.82M
| $123K | ﹤0.01% |
202
+171
| +552% | +$120K |
|
3428
Mexco Energy
MXC
$20M
| $123K | ﹤0.01% |
10,200
-1,200
| -11% | -$14K |
|
3429
Oramed Pharmaceuticals
ORMP
$178M
| $121K | ﹤0.01% |
33,700
+21,800
| +183% | +$69.9K |
|
|
PPTA
3430
Perpetua Resources
PPTA
$3.16B
| $121K | ﹤0.01% |
32,886
+18,786
| +133% | +$86.4K |
|
|
AIM
3431
AIM ImmunoTech
AIM
$7.13M
| $120K | ﹤0.01% |
1,790
+101
| +6% | +$4.87K |
|
3432
Antelope Enterprise Holdings
AEHL
$5.76M
| $119K | ﹤0.01% |
4
+3
| +300% | +$124K |
|
3433
OptimumBank Holdings
OPHC
$113M
| $119K | ﹤0.01% |
41,300
-3,900
| -9% | -$11.9K |
|
|
QNTM
3434
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$22.4M
| $118K | ﹤0.01% |
1,578
+516
| +49% | +$44.3K |
|
3435
Aptevo Therapeutics
APVO
$5.31M
| – | – |
0
| – | – |
|
3436
Data Storage Corp
DTST
$7.97M
| $117K | ﹤0.01% |
+50,401
| New | +$96.8K |
|
3437
Geospace Technologies
GEOS
$67.9M
| $117K | ﹤0.01% |
15,100
-10,600
| -41% | -$84.2K |
|
3438
Boxlight
BOXL
$5.25M
| $116K | ﹤0.01% |
291
+62
| +27% | +$28.8K |
|
|
CARV
3439
DELISTED
Carver Bancorp
CARV
| $116K | ﹤0.01% |
43,568
-7,208
| -14% | -$28.3K |
|
|
CLEU
3440
DELISTED
China Liberal Education Holdings
CLEU
| $116K | ﹤0.01% |
6
-3
| -33% | -$42.2K |
|
3441
DSS Inc
DSS
$5.15M
| $115K | ﹤0.01% |
15,988
+594
| +4% | +$2.61K |
|
3442
PDS Biotechnology
PDSB
$13.5M
| $115K | ﹤0.01% |
22,862
-342,875
| -94% | -$2.25M |
|
|
LBPH
3443
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $115K | ﹤0.01% |
+15,700
| New | +$119K |
|
3444
Vor Biopharma
VOR
$1.32B
| $112K | ﹤0.01% |
1,820
+400
| +28% | +$36.5K |
|
|
ZEPP
3445
Zepp Health
ZEPP
$79.9M
| $112K | ﹤0.01% |
24,550
-350
| -1% | -$1.76K |
|
3446
Bridgeline Digital
BLIN
$13.7M
| $111K | ﹤0.01% |
94,188
-49,656
| -35% | -$49.8K |
|
3447
IZEA Worldwide
IZEA
$53.8M
| $111K | ﹤0.01% |
46,025
+10,725
| +30% | +$28K |
|
|
SKE
3448
Skeena Resources
SKE
$4.12B
| $111K | ﹤0.01% |
+23,003
| New | +$135K |
|
3449
Dominari Holdings
DOMH
$70.8M
| $109K | ﹤0.01% |
37,326
+2,400
| +7% | +$7.25K |
|
|
CNTB
3450
Connect Biopharma Holdings
CNTB
$147M
| $108K | ﹤0.01% |
95,500
+6,400
| +7% | +$7.17K |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.